{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:32:06Z","timestamp":1793881926482,"version":"4.7.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Shandong Provincial Medical Association","award":["YXH2022ZX02131"],"award-info":[{"award-number":["YXH2022ZX02131"]}]},{"name":"Shandong Province Medical and Health Technology Project","award":["202303110352"],"award-info":[{"award-number":["202303110352"]}]},{"name":"Chen Xiao-Ping Foundation for the Development of Science and Technology of HuBei Province","award":["CXPJJH124001-2475"],"award-info":[{"award-number":["CXPJJH124001-2475"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic liver injury is a key factor in diseases like hepatocellular carcinoma (HCC), steatohepatitis (NASH), and viral hepatitis type B and C (HBV, HCV). Understanding its molecular mechanisms is crucial for effective treatment. The NOTCH1 signaling pathway, though not fully understood, is implicated in liver injury and may be a potential therapeutic target.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Clinical HCC, HBV, HCV and NASH samples and additional in vitro and in vivo performances were subjected to confirm the role of NOTCH1 and its downstream targets via a series of biochemical assays, molecular analysis approaches and targeted signaling pathway assay, etc.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The present study first verified the abnormal elevation of NOTCH1 in hepatocytes from patients with steatohepatitis, HCC, HBV, HCV, and mouse models. Crucially, we discovered that hepatocyte-specific\n                      <jats:italic>NOTCH1<\/jats:italic>\n                      knockout reduces hepatocellular damage in chronic liver inflammation and HCC mouse models, whereas adeno-associated virus serotype 8 (AAV8)-mediated NOTCH1 overexpression in hepatocytes exacerbates liver injury-related phenotype on-setting. Mechanistically, we showed that NOTCH1 has a new role in controlling ferroptosis and oxidative damage in hepatocytes. It interacts with Kelch-like ECH-associated protein 1 (KEAP1) and is directly recruited through its intracellular domain (NICD1). Additionally, the KEAP1 recruited by NOTCH1 impeded the binding stability of KEAP1-NFE2 like BZIP transcription factor 2 (Nrf2), promote the separation of KEAP1 and Nrf2, thereby reducing the stability of Nrf2 and hindering the ubiquitination-related proteasome degradation of Nrf2. Crucially, we also discovered that NOTCH1\u2019s ANK domain is essential for NICD1-KEAP1 contacts and signaling activation. The inability of NOTCH1 with ANK domain mutants (\u0394ANK) to connect with KEAP1 and increase its expression emphasizes the importance of the ANK domain in KEAP1-NRF2 signaling. By reversing the downregulation of KEAP1 and the overexpression of NRF2, ANK function is linked to ferroptosis and ROS buildup. ANK domain targeting may slow the course of HCC and liver damage.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Targeting the NOTCH1-KEAP1-NRF2 axis as a possible chronic hepatic injury therapy is supported by these findings, which identify NOTCH1-KEAP1 as an NRF2 suppressor that accelerates the progression of liver injury.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-025-03488-3","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T02:43:49Z","timestamp":1754707429000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Targeting NOTCH1-KEAP1 axis retards chronic liver injury and liver cancer progression via regulating stabilization of NRF2"],"prefix":"10.1186","volume":"44","author":[{"given":"Chunxiao","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihao","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengbin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,9]]},"reference":[{"issue":"2","key":"3488_CR1","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. 2023;79(2):516\u201337.","journal-title":"J Hepatol"},{"issue":"8","key":"3488_CR2","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/S2468-1253(22)00050-4","volume":"7","author":"CJ Alberts","year":"2022","unstructured":"Alberts CJ, Clifford GM, Georges D, Negro F, Lesi OA, Hutin YJ, de Martel C. Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review. Lancet Gastroenterol Hepatol. 2022;7(8):724\u201335.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10","key":"3488_CR3","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","volume":"20","author":"L Hammerich","year":"2023","unstructured":"Hammerich L, Tacke F. Hepatic inflammatory responses in liver fibrosis. Nat Reviews Gastroenterol Hepatol. 2023;20(10):633\u201346.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"issue":"2","key":"3488_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/CMR.00232-20","volume":"34","author":"NM G\u00e1lvez","year":"2021","unstructured":"G\u00e1lvez NM, Bohmwald K, Pacheco GA, Andrade CA, Carre\u00f1o LJ, Kalergis AM. Type I natural killer T cells as key regulators of the immune response to infectious diseases. Clin Microbiol Rev. 2021;34(2):10\u20131128.","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"3488_CR5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jhep.2024.08.029","volume":"82","author":"M Xu","year":"2025","unstructured":"Xu M, Zhao J, Zhu L, Ge C, Sun Y, Wang R, Shi S. Targeting PYK2 with heterobifunctional T6BP helps mitigate MASLD and MASH-HCC progression. J Hepatol. 2025;82(2):277\u2013300.","journal-title":"J Hepatol"},{"issue":"1","key":"3488_CR6","doi-asserted-by":"publisher","first-page":"6384","DOI":"10.1038\/s41467-023-42040-9","volume":"14","author":"M Xu","year":"2023","unstructured":"Xu M, Tan J, Liu X, Han L, Ge C, Zhang Y, Han L. Tripartite motif containing 26 prevents steatohepatitis progression by suppressing C\/EBP\u03b4 signalling activation. Nat Commun. 2023;14(1):6384.","journal-title":"Nat Commun"},{"issue":"1","key":"3488_CR7","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/s41467-022-28641-w","volume":"13","author":"M Xu","year":"2022","unstructured":"Xu M, Tan J, Dong W, Zou B, Teng X, Zhu L, Wang B. The E3 ubiquitin-protein ligase Trim31 alleviates non-alcoholic fatty liver disease by targeting Rhbdf2 in mouse hepatocytes. Nat Commun. 2022;13(1):1052.","journal-title":"Nat Commun"},{"key":"3488_CR8","doi-asserted-by":"publisher","first-page":"102274","DOI":"10.1016\/j.redox.2022.102274","volume":"51","author":"C Ge","year":"2022","unstructured":"Ge C, Tan J, Lou D, Zhu L, Zhong Z, Dai X, Xu M. Mulberrin confers protection against hepatic fibrosis by Trim31\/Nrf2 signaling. Redox Biol. 2022;51:102274.","journal-title":"Redox Biol"},{"key":"3488_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/liv.14102","volume":"39","author":"L Fouassier","year":"2019","unstructured":"Fouassier L, Marzioni M, Afonso MB, Dooley S, Gaston K, Giannelli G, Coulouarn C. Signalling networks in cholangiocarcinoma: molecular pathogenesis, targeted therapies and drug resistance. Liver Int. 2019;39:43\u201362.","journal-title":"Liver Int"},{"issue":"18","key":"3488_CR10","doi-asserted-by":"publisher","first-page":"4566","DOI":"10.3390\/cancers15184566","volume":"15","author":"A Kakehashi","year":"2023","unstructured":"Kakehashi A, Suzuki S, Wanibuchi H. Recent insights into the biomarkers, molecular targets and mechanisms of non-alcoholic steatohepatitis-driven hepatocarcinogenesis. Cancers. 2023;15(18):4566.","journal-title":"Cancers"},{"issue":"9","key":"3488_CR11","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/cac2.12591","volume":"44","author":"F Zhang","year":"2024","unstructured":"Zhang F, Guo J, Yu S, Zheng Y, Duan M, Zhao L, Jiang X. Cellular senescence and metabolic reprogramming: unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment. Cancer Commun. 2024;44(9):929\u201366.","journal-title":"Cancer Commun"},{"issue":"9","key":"3488_CR12","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41568-021-00383-9","volume":"21","author":"X Li","year":"2021","unstructured":"Li X, Ramadori P, Pfister D, Seehawer M, Zender L, Heikenwalder M. The immunological and metabolic landscape in primary and metastatic liver cancer. Nat Rev Cancer. 2021;21(9):541\u201357.","journal-title":"Nat Rev Cancer"},{"key":"3488_CR13","doi-asserted-by":"crossref","unstructured":"Kang J, Postigo-Fernandez J, Kim K, Zhu C, Yu J, Meroni M, Pajvani UB. Notch-mediated hepatocyte MCP-1 secretion causes liver fibrosis. JCI Insight, 2023;8(3):e165369.","DOI":"10.1172\/jci.insight.165369"},{"issue":"3","key":"3488_CR14","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.jhep.2020.09.032","volume":"74","author":"C Zhu","year":"2021","unstructured":"Zhu C, Ho YJ, Salomao MA, Dapito DH, Bartolome A, Schwabe RF, Pajvani UB. Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features. J Hepatol. 2021;74(3):613\u201326.","journal-title":"J Hepatol"},{"key":"3488_CR15","doi-asserted-by":"crossref","unstructured":"Saha D, Dutta P, Rebello KR, Shankar A, Chakraborty A. Exploring the potential link between human papillomavirus infection and coronary artery disease: a review of shared pathways and mechanisms. Mol Cell Biochem, 2025:1\u201324.","DOI":"10.1007\/s11010-025-05236-9"},{"issue":"1","key":"3488_CR16","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1038\/s41467-024-45716-y","volume":"15","author":"R Thambyrajah","year":"2024","unstructured":"Thambyrajah R, Maqueda M, Neo WH, Imbach K, Guill\u00e9n Y, Grases D, Bigas A. Cis Inhibition of NOTCH1 through JAGGED1 sustains embryonic hematopoietic stem cell fate. Nat Commun. 2024;15(1):1604.","journal-title":"Nat Commun"},{"issue":"26","key":"3488_CR17","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1182\/blood.2023023559","volume":"143","author":"Y Sun","year":"2024","unstructured":"Sun Y, Tong H, Chu X, Li Y, Zhang J, Ding Y, Qiao J. Notch1 regulates hepatic thrombopoietin production. Blood. 2024;143(26):2778\u201390.","journal-title":"Blood"},{"key":"3488_CR18","doi-asserted-by":"publisher","first-page":"121438","DOI":"10.1016\/j.lfs.2023.121438","volume":"317","author":"Q Zhou","year":"2023","unstructured":"Zhou Q, Li B, Li J. DLL4-Notch signalling in acute-on-chronic liver failure: state of the Art and perspectives. Life Sci. 2023;317:121438.","journal-title":"Life Sci"},{"key":"3488_CR19","doi-asserted-by":"publisher","first-page":"107938","DOI":"10.1016\/j.intimp.2021.107938","volume":"99","author":"W Chen","year":"2021","unstructured":"Chen W, Liu Y, Chen J, Ma Y, Song Y, Cen Y, Yang G. The Notch signaling pathway regulates macrophage polarization in liver diseases. Int Immunopharmacol. 2021;99:107938.","journal-title":"Int Immunopharmacol"},{"issue":"468","key":"3488_CR20","doi-asserted-by":"publisher","first-page":"eaat0344","DOI":"10.1126\/scitranslmed.aat0344","volume":"10","author":"C Zhu","year":"2018","unstructured":"Zhu C, Kim K, Wang X, Bartolome A, Salomao M, Dongiovanni P, Pajvani UB. Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis. Sci Transl Med. 2018;10(468):eaat0344.","journal-title":"Sci Transl Med"},{"issue":"8","key":"3488_CR21","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1002\/oby.22873","volume":"28","author":"T Auguet","year":"2020","unstructured":"Auguet T, Bertran L, Binetti J, Aguilar C, Mart\u00ednez S, Guiu-Jurado E, Richart C. Hepatocyte Notch signaling deregulation related to lipid metabolism in women with obesity and nonalcoholic fatty liver. Obesity. 2020;28(8):1487\u201393.","journal-title":"Obesity"},{"issue":"599","key":"3488_CR22","doi-asserted-by":"publisher","first-page":"eabe1692","DOI":"10.1126\/scitranslmed.abe1692","volume":"13","author":"J Yu","year":"2021","unstructured":"Yu J, Zhu C, Wang X, Kim K, Bartolome A, Dongiovanni P, Pajvani UB. Hepatocyte TLR4 triggers inter-hepatocyte Jagged1\/Notch signaling to determine NASH-induced fibrosis. Sci Transl Med. 2021;13(599):eabe1692.","journal-title":"Sci Transl Med"},{"issue":"4","key":"3488_CR23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3390\/livers2040023","volume":"2","author":"L de la Conde","year":"2022","unstructured":"de la Conde L, Goicoechea L, Torres S, Garcia-Ruiz C, Fernandez-Checa JC. Role of oxidative stress in liver disorders. Livers. 2022;2(4):283\u2013314.","journal-title":"Livers"},{"key":"3488_CR24","doi-asserted-by":"crossref","unstructured":"Li X, Li Y, Zhang W, Jiang F, Lin L, Wang Y, Zheng J. The IGF2BP3\/Notch\/Jag1 pathway: a key regulator of hepatic stellate cell ferroptosis in liver fibrosis. Clin Translational Med, 2024;14(8):e1793.","DOI":"10.1002\/ctm2.1793"},{"issue":"8","key":"3488_CR25","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1080\/15548627.2019.1687985","volume":"16","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Guo M, Li Y, Shen M, Kong D, Shao J, Zheng S. RNA-binding protein ZFP36\/TTP protects against ferroptosis by regulating autophagy signaling pathway in hepatic stellate cells. Autophagy. 2020;16(8):1482\u2013505.","journal-title":"Autophagy"},{"issue":"3","key":"3488_CR26","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41418-022-00941-0","volume":"29","author":"J Chen","year":"2022","unstructured":"Chen J, Li X, Ge C, Min J, Wang F. The multifaceted role of ferroptosis in liver disease. Cell Death Differ. 2022;29(3):467\u201380.","journal-title":"Cell Death Differ"},{"issue":"1","key":"3488_CR27","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41420-021-00579-w","volume":"7","author":"Y Yu","year":"2021","unstructured":"Yu Y, Yan Y, Niu F, Wang Y, Chen X, Su G, Xiong Y. Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases. Cell Death Discovery. 2021;7(1):193.","journal-title":"Cell Death Discovery"},{"issue":"8","key":"3488_CR28","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.cmet.2022.07.006","volume":"34","author":"H Gao","year":"2022","unstructured":"Gao H, Jin Z, Bandyopadhyay G, Wang G, Zhang D, Rocha e, Ying KC, W. Aberrant iron distribution via hepatocyte-stellate cell axis drives liver lipogenesis and fibrosis. Cell Metabol. 2022;34(8):1201\u201313.","journal-title":"Cell Metabol"},{"issue":"5","key":"3488_CR29","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/s41401-022-01010-5","volume":"44","author":"J Tong","year":"2023","unstructured":"Tong J, Lan XT, Zhang Z, Liu Y, Sun DY, Wang XJ, Li DJ. Ferroptosis inhibitor liproxstatin-1 alleviates metabolic dysfunction-associated fatty liver disease in mice: potential involvement of PANoptosis. Acta Pharmacol Sin. 2023;44(5):1014\u201328.","journal-title":"Acta Pharmacol Sin"},{"key":"3488_CR30","doi-asserted-by":"publisher","first-page":"118162","DOI":"10.1016\/j.jep.2024.118162","volume":"329","author":"Z Xu","year":"2024","unstructured":"Xu Z, Li J, Zhou K, Wang K, Hu H, Hu Y, Huang J. Exocarpium citri grandis ameliorates LPS-induced acute lung injury by suppressing inflammation, NLRP3 inflammasome, and ferroptosis. J Ethnopharmacol. 2024;329:118162.","journal-title":"J Ethnopharmacol"},{"key":"3488_CR31","doi-asserted-by":"publisher","first-page":"1447060","DOI":"10.3389\/fimmu.2024.1447060","volume":"15","author":"S Wang","year":"2024","unstructured":"Wang S, Zhang K, Huang Q, Meng F, Deng S. TLR4 signalling in ischemia\/reperfusion injury: a promising target for linking inflammation, oxidative stress and programmed cell death to improve organ transplantation outcomes. Front Immunol. 2024;15:1447060.","journal-title":"Front Immunol"},{"key":"3488_CR32","doi-asserted-by":"publisher","first-page":"106915","DOI":"10.1016\/j.phrs.2023.106915","volume":"196","author":"W Bao","year":"2023","unstructured":"Bao W, Wang J, Fan K, Gao Y, Chen J. PIAS3 promotes ferroptosis by regulating TXNIP via TGF-\u03b2 signaling pathway in hepatocellular carcinoma. Pharmacol Res. 2023;196:106915.","journal-title":"Pharmacol Res"},{"key":"3488_CR33","doi-asserted-by":"publisher","first-page":"103029","DOI":"10.1016\/j.redox.2024.103029","volume":"69","author":"Y Fu","year":"2024","unstructured":"Fu Y, Zhou X, Wang L, Fan W, Gao S, Zhang D, Liu P. Salvianolic acid B attenuates liver fibrosis by targeting Ecm1 and inhibiting hepatocyte ferroptosis. Redox Biol. 2024;69:103029.","journal-title":"Redox Biol"},{"issue":"3","key":"3488_CR34","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1002\/hep.24469","volume":"54","author":"HC Yu","year":"2011","unstructured":"Yu HC, Qin HY, He F, Wang L, Fu W, Liu D, Han H. Canonical Notch pathway protects hepatocytes from ischemia\/reperfusion injury in mice by repressing reactive oxygen species production through JAK2\/STAT3 signaling. Hepatology. 2011;54(3):979\u201388.","journal-title":"Hepatology"},{"issue":"1","key":"3488_CR35","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00018-024-05143-0","volume":"81","author":"JW Kang","year":"2024","unstructured":"Kang JW, He JP, Liu YN, Zhang Y, Song SS, Xu QX, Su RW. Aberrant activated Notch1 promotes prostate enlargement driven by androgen signaling via disrupting mitochondrial function in mouse. Cell Mol Life Sci. 2024;81(1):155.","journal-title":"Cell Mol Life Sci"},{"key":"3488_CR36","doi-asserted-by":"publisher","first-page":"103160","DOI":"10.1016\/j.redox.2024.103160","volume":"72","author":"J Zhao","year":"2024","unstructured":"Zhao J, Ma W, Wang S, Zhang K, Xiong Q, Li Y, Du H. Differentiation of intestinal stem cells toward goblet cells under systemic iron overload stress are associated with Inhibition of Notch signaling pathway and ferroptosis. Redox Biol. 2024;72:103160.","journal-title":"Redox Biol"},{"issue":"20","key":"3488_CR37","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.1038\/s44318-024-00176-4","volume":"43","author":"MA Banu","year":"2024","unstructured":"Banu MA, Dovas A, Argenziano MG, Zhao W, Sperring CP, Grajal C, Canoll H, P. A cell state-specific metabolic vulnerability to GPX4-dependent ferroptosis in glioblastoma. EMBO J. 2024;43(20):4492\u2013521.","journal-title":"EMBO J"},{"key":"3488_CR38","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.freeradbiomed.2023.04.022","volume":"204","author":"DY Ma","year":"2023","unstructured":"Ma DY, Liu JX, Wang LD, Zhi XY, Luo L, Zhao JY, Qin Y. GSK-3\u03b2-dependent Nrf2 antioxidant response modulates ferroptosis of lens epithelial cells in age-related cataract. Free Radic Biol Med. 2023;204:161\u201376.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"3488_CR39","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s12031-021-01890-y","volume":"72","author":"MY Li","year":"2022","unstructured":"Li MY, Dai XH, Yu XP, Zou W, Teng W, Liu P, Wen X. Scalp acupuncture protects against neuronal ferroptosis by activating the p62-Keap1-Nrf2 pathway in rat models of intracranial haemorrhage. J Mol Neurosci. 2022;72(1):82\u201396.","journal-title":"J Mol Neurosci"},{"key":"3488_CR40","doi-asserted-by":"publisher","first-page":"1403227","DOI":"10.3389\/fphar.2024.1403227","volume":"15","author":"L Liang","year":"2024","unstructured":"Liang L, Mi Y, Zhou S, Yang A, Wei C, Dai E. Advances in the study of key cells and signaling pathways in renal fibrosis and the interventional role of Chinese medicines. Front Pharmacol. 2024;15:1403227.","journal-title":"Front Pharmacol"},{"issue":"4","key":"3488_CR41","doi-asserted-by":"publisher","first-page":"100651","DOI":"10.1016\/j.jhepr.2022.100651","volume":"5","author":"K Seedorf","year":"2023","unstructured":"Seedorf K, Weber C, Vinson C, Berger S, Vuillard LM, Kiss A, Delerive P. Selective disruption of NRF2-KEAP1 interaction leads to NASH resolution and reduction of liver fibrosis in mice. Jhep Rep. 2023;5(4):100651.","journal-title":"Jhep Rep"},{"key":"3488_CR42","doi-asserted-by":"publisher","first-page":"102570","DOI":"10.1016\/j.redox.2022.102570","volume":"59","author":"P Liu","year":"2023","unstructured":"Liu P, Anandhan A, Chen J, Shakya A, Dodson M, Ooi A, Zhang DD. Decreased autophagosome biogenesis, reduced NRF2, and enhanced ferroptotic cell death are underlying molecular mechanisms of non-alcoholic fatty liver disease. Redox Biol. 2023;59:102570.","journal-title":"Redox Biol"},{"key":"3488_CR43","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.freeradbiomed.2022.01.015","volume":"180","author":"C Sun","year":"2022","unstructured":"Sun C, Han B, Zhai Y, Zhao H, Li X, Qian J, Kai G. Dihydrotanshinone I inhibits ovarian tumor growth by activating oxidative stress through Keap1-mediated Nrf2 ubiquitination degradation. Free Radic Biol Med. 2022;180:220\u201335.","journal-title":"Free Radic Biol Med"},{"key":"3488_CR44","doi-asserted-by":"publisher","first-page":"112185","DOI":"10.1016\/j.ecoenv.2021.112185","volume":"216","author":"Q Ke","year":"2021","unstructured":"Ke Q, Yang J, Liu H, Huang Z, Bu L, Jin D, Liu C. Dose-and time-effects responses of nonylphenol on oxidative stress in rat through the Keap1-Nrf2 signaling pathway. Ecotoxicol Environ Saf. 2021;216:112185.","journal-title":"Ecotoxicol Environ Saf"},{"key":"3488_CR45","doi-asserted-by":"crossref","unstructured":"Bhat AA, Moglad E, Goyal A, Afzal M, Thapa R, Almalki WH, Gupta G. Nrf2 pathways in neuroprotection: alleviating mitochondrial dysfunction and cognitive impairment in aging. Life Sci, 2024:123056.","DOI":"10.1016\/j.lfs.2024.123056"},{"key":"3488_CR46","doi-asserted-by":"publisher","first-page":"110262","DOI":"10.1016\/j.cbi.2022.110262","volume":"369","author":"S Cai","year":"2023","unstructured":"Cai S, Ding Z, Liu X, Zeng J. Trabectedin induces ferroptosis via regulation of HIF-1\u03b1\/IRP1\/TFR1 and Keap1\/Nrf2\/GPX4 axis in non-small cell lung cancer cells. Chemico-Biol Interact. 2023;369:110262.","journal-title":"Chemico-Biol Interact"},{"issue":"1","key":"3488_CR47","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s11658-022-00383-z","volume":"27","author":"Y Li","year":"2022","unstructured":"Li Y, Xu B, Ren X, Wang L, Xu Y, Zhao Y, Du J. Inhibition of CISD2 promotes ferroptosis through ferritinophagy-mediated ferritin turnover and regulation of p62\u2013Keap1\u2013NRF2 pathway. Cell Mol Biol Lett. 2022;27(1):81.","journal-title":"Cell Mol Biol Lett"},{"issue":"12","key":"3488_CR48","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.molcel.2022.03.022","volume":"82","author":"D Liang","year":"2022","unstructured":"Liang D, Minikes AM, Jiang X. Ferroptosis at the intersection of lipid metabolism and cellular signaling. Mol Cell. 2022;82(12):2215\u201327.","journal-title":"Mol Cell"},{"issue":"4","key":"3488_CR49","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.7150\/ijbs.63297","volume":"18","author":"H Xu","year":"2022","unstructured":"Xu H, Wan XD, Zhu RR, Liu JL, Liu JC, Zhou XL. Keap-NRF2 signaling contributes to the Notch1 protected heart against ischemic reperfusion injury via regulating mitochondrial ROS generation and bioenergetics. Int J Biol Sci. 2022;18(4):1651.","journal-title":"Int J Biol Sci"},{"issue":"2","key":"3488_CR50","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1166\/jbt.2021.2543","volume":"11","author":"Q Hong","year":"2021","unstructured":"Hong Q, Ye J, Wang X, Zhang C. The mechanism of Gastrodin participating in improving the cerebral ischemia-reperfusion injury through Notch 1 and NF-\u03baB signaling pathways. J Biomaterials Tissue Eng. 2021;11(2):271\u20135.","journal-title":"J Biomaterials Tissue Eng"},{"key":"3488_CR51","doi-asserted-by":"publisher","first-page":"103640","DOI":"10.1016\/j.etap.2021.103640","volume":"85","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Wang L, Yu X, Jiang S, Wang X, Xing Y, Liu J. Cr (VI) promotes tight joint and oxidative damage by activating the Nrf2\/ROS\/Notch1 axis. Environ Toxicol Pharmacol. 2021;85:103640.","journal-title":"Environ Toxicol Pharmacol"},{"issue":"1","key":"3488_CR52","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12964-022-00886-4","volume":"20","author":"F Vujovic","year":"2022","unstructured":"Vujovic F, Hunter N, Farahani RM. Notch Ankyrin domain: evolutionary rise of a thermodynamic sensor. Cell Communication Signal. 2022;20(1):66.","journal-title":"Cell Communication Signal"},{"issue":"1","key":"3488_CR53","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1038\/s41467-022-30396-3","volume":"13","author":"N Baran","year":"2022","unstructured":"Baran N, Lodi A, Dhungana Y, Herbrich S, Collins M, Sweeney S, Konopleva M. Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia. Nat Commun. 2022;13(1):2801.","journal-title":"Nat Commun"},{"key":"3488_CR54","doi-asserted-by":"crossref","unstructured":"Wang, K., Li, L., Kenny, S., Gan, D., Reitsma, J. M., Zhou, Y.,\u2026 Liu, X. (2025).Molecular mechanisms of CAND2 in regulating SCF ubiquitin ligases. Nature Communications,16(1), 1998.","DOI":"10.1038\/s41467-025-57065-5"},{"key":"3488_CR55","doi-asserted-by":"crossref","unstructured":"Wang, T., Zhou, Y., Zhou, Z., Zhang, P., Yan, R., Sun, L.,\u2026 Zhang, H. (2023). Secreted protease PRSS35 suppresses hepatocellular carcinoma by disabling CXCL2-mediated neutrophil extracellular traps. Nature communications, 14(1), 1513.","DOI":"10.1038\/s41467-023-37227-z"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03488-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03488-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03488-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T15:46:51Z","timestamp":1757346411000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-025-03488-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,9]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3488"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03488-3","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,9]]},"assertion":[{"value":"8 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The use of clinical samples was approved by the ethics committee of Shandong First Medical University & Shandong Academy of Medical Sciences and informed consent were obtained from all patients (2024LC0001). All animal experimental protocols were performed following the Ethical Animal Care and Use Committee of Shandong University (2022JJCA08).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to the publication of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"232"}}